.png){kind=small}
Streamlines tasks, enhances productivity with intelligent automation.
AQEMIA applies physics-based AI to drug discovery, combining generative AI with deep physics to develop new medicines for unmet medical needs, including oncology. It is based in Paris and London. The company positions itself as going beyond conventional and AI-augmented discovery methods. It suits pharmaceutical and biotech organisations looking to accelerate the development of new therapeutic candidates.
Similar tools
Same job, different trade-offs.
Enhancing oncology precision with AI-driven, rapid cancer assessments.
Revolutionizes healthcare call centers with AI-driven efficiency and integration.
Accelerate drug discovery, reduce costs, and improve lives with AI-powered candidate selection for clinical trials.